The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study
Diego Raimondo(Azienda USL di Bologna), Renato Seracchioli(Azienda USL di Bologna), Stefano Restaino(University of Udine), Jacopo Lenzi, Giovanni Scambia(Agostino Gemelli University Polyclinic), F. Mascilini(Università Cattolica del Sacro Cuore), Paolo Casadio(Azienda USL di Bologna), Giuseppe Vizzielli(University of Udine), Rita Trozzi(Università Cattolica del Sacro Cuore), Antonio Raffone(University of Campania "Luigi Vanvitelli"), Antonio Travaglino(University of Insubria), Manuela Maletta(University of Bologna), Jessica Mauro(Ospedale San Pietro Fatebenefratelli), Antonio Mollo(Northwestern University), Anna Fagotti, Lorenza Driul(University of Udine)
Cited by 7
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299